Peripheral blood tests, such as NLR, PLR, LMR, red cell volume distribution width (RDW), albumin/globulin ratio (AGR), albumin/gamma-glutamyl transferase ratio (AGgR) and fibrinogen, can refine patient stratification to therapy and predict survival outcomes in gliomas (11–14). The gene discussed is ALB; the disease is glioma.